Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 9 of 9 entries
Sorted by: Best Match Show Resources per page
Correction to: Novel Mutations in RASGRP1 Are Associated with Immunodeficiency, Immune Dysregulation, and EBV-Induced Lymphoma.

Journal of clinical immunology

Somekh I, Marquardt B, Liu Y, Rohlfs M, Hollizeck S, Karakukcu M, Unal E, Yilmaz E, Patiroglu T, Cansever M, Frizinsky S, Vishnvenskia-Dai V, Rechavi E, Stauber T, Simon AJ, Lev A, Klein C, Kotlarz D, Somech R.
PMID: 30099695
J Clin Immunol. 2018 Aug;38(6):711. doi: 10.1007/s10875-018-0541-8.

The original version of this article unfortunately contained mistakes in Author's name, in Table 1 and in result section.

Cite
Somekh I, Marquardt B, Liu Y, et al. Correction to: Novel Mutations in RASGRP1 Are Associated with Immunodeficiency, Immune Dysregulation, and EBV-Induced Lymphoma. J Clin Immunol. 2018;38(6):711doi: 10.1007/s10875-018-0541-8.
Somekh, I., Marquardt, B., Liu, Y., Rohlfs, M., Hollizeck, S., Karakukcu, M., Unal, E., Yilmaz, E., Patiroglu, T., Cansever, M., Frizinsky, S., Vishnvenskia-Dai, V., Rechavi, E., Stauber, T., Simon, A. J., Lev, A., Klein, C., Kotlarz, D., & Somech, R. (2018). Correction to: Novel Mutations in RASGRP1 Are Associated with Immunodeficiency, Immune Dysregulation, and EBV-Induced Lymphoma. Journal of clinical immunology, 38(6), 711. https://doi.org/10.1007/s10875-018-0541-8
Somekh, Ido, et al. "Correction to: Novel Mutations in RASGRP1 Are Associated with Immunodeficiency, Immune Dysregulation, and EBV-Induced Lymphoma." Journal of clinical immunology vol. 38,6 (2018): 711. doi: https://doi.org/10.1007/s10875-018-0541-8
Somekh I, Marquardt B, Liu Y, Rohlfs M, Hollizeck S, Karakukcu M, Unal E, Yilmaz E, Patiroglu T, Cansever M, Frizinsky S, Vishnvenskia-Dai V, Rechavi E, Stauber T, Simon AJ, Lev A, Klein C, Kotlarz D, Somech R. Correction to: Novel Mutations in RASGRP1 Are Associated with Immunodeficiency, Immune Dysregulation, and EBV-Induced Lymphoma. J Clin Immunol. 2018 Aug;38(6):711. doi: 10.1007/s10875-018-0541-8. PMID: 30099695.
Copy Download .nbib Format: NLM
Conjunctival ulceration in Behçet disease: a case report.

BMJ case reports

Fabian ID, Vishnevskia-Dai V.
PMID: 21918669
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.08.2008.0616. Epub 2009 Sep 15.

Behçet disease is a chronic systemic relapsing vasculitis. Ocular clinical signs in Behçet disease usually include signs of inflammation in the uvea, vitreous and retina. This report describes a rare case of a full-blown systemic exacerbation of Behçet disease...

Cite
Fabian ID, Vishnevskia-Dai V. Conjunctival ulceration in Behçet disease: a case report. BMJ Case Rep. 2009;2009doi: 10.1136/bcr.08.2008.0616.
Fabian, I. D., & Vishnevskia-Dai, V. (2009). Conjunctival ulceration in Behçet disease: a case report. BMJ case reports, 2009. https://doi.org/10.1136/bcr.08.2008.0616
Fabian, Ido Didi, and Vishnevskia-Dai, Vicktoria. "Conjunctival ulceration in Behçet disease: a case report." BMJ case reports vol. 2009 (2009). doi: https://doi.org/10.1136/bcr.08.2008.0616
Fabian ID, Vishnevskia-Dai V. Conjunctival ulceration in Behçet disease: a case report. BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.08.2008.0616. Epub 2009 Sep 15. PMID: 21918669; PMCID: PMC3027929.
Copy Download .nbib Format: NLM
Primary Vitreoretinal Lymphoma Masquerading as Refractory Retinitis.

Case reports in ophthalmology

Zloto O, Elkader AE, Fabian ID, Vishnevskia-Dai V.
PMID: 26557084
Case Rep Ophthalmol. 2015 Oct 07;6(3):345-50. doi: 10.1159/000440762. eCollection 2015.

PURPOSE: To report a case of a patient with primary vitreoretinal lymphoma masquerading as retinitis.METHODS: Retrospective review of the patient's clinical, histopathological and imaging records.RESULTS: Cytopathology was negative for malignancy, and preliminary polymerase chain reaction results supported the diagnosis...

Cite
Zloto O, Elkader AE, Fabian ID, et al. Primary Vitreoretinal Lymphoma Masquerading as Refractory Retinitis. Case Rep Ophthalmol. 2015;6(3):345-50doi: 10.1159/000440762.
Zloto, O., Elkader, A. E., Fabian, I. D., & Vishnevskia-Dai, V. (2015). Primary Vitreoretinal Lymphoma Masquerading as Refractory Retinitis. Case reports in ophthalmology, 6(3), 345-50. https://doi.org/10.1159/000440762
Zloto, Ofira, et al. "Primary Vitreoretinal Lymphoma Masquerading as Refractory Retinitis." Case reports in ophthalmology vol. 6,3 (2015): 345-50. doi: https://doi.org/10.1159/000440762
Zloto O, Elkader AE, Fabian ID, Vishnevskia-Dai V. Primary Vitreoretinal Lymphoma Masquerading as Refractory Retinitis. Case Rep Ophthalmol. 2015 Oct 07;6(3):345-50. doi: 10.1159/000440762. eCollection 2015. PMID: 26557084; PMCID: PMC4637799.
Copy Download .nbib Format: NLM
UVEITIS AFTER THE BNT162b2 mRNA VACCINATION AGAINST SARS-CoV-2 INFECTION: A Possible Association.

Retina (Philadelphia, Pa.)

Rabinovitch T, Ben-Arie-Weintrob Y, Hareuveni-Blum T, Shaer B, Vishnevskia-Dai V, Shulman S, Newman H, Biadsy M, Masarwa D, Fischer N, Yovel O, Goldfeather-Ben Zaken S, Habot-Wilner Z.
PMID: 34369440
Retina. 2021 Dec 01;41(12):2462-2471. doi: 10.1097/IAE.0000000000003277.

PURPOSE: To describe uveitis cases after the BNT162b2 mRNA SARS-CoV-2 vaccination.METHODS: This is a multicenter, retrospective study. Vaccine-related uveitis diagnosis was supported by the classification of the World Health Organization Adverse Drug Terminology and the Naranjo criteria.RESULTS: Twenty-one patients...

Cite
Rabinovitch T, Ben-Arie-Weintrob Y, Hareuveni-Blum T, et al. UVEITIS AFTER THE BNT162b2 mRNA VACCINATION AGAINST SARS-CoV-2 INFECTION: A Possible Association. Retina. 2021;41(12):2462-2471doi: 10.1097/IAE.0000000000003277.
Rabinovitch, T., Ben-Arie-Weintrob, Y., Hareuveni-Blum, T., Shaer, B., Vishnevskia-Dai, V., Shulman, S., Newman, H., Biadsy, M., Masarwa, D., Fischer, N., Yovel, O., Goldfeather-Ben Zaken, S., & Habot-Wilner, Z. (2021). UVEITIS AFTER THE BNT162b2 mRNA VACCINATION AGAINST SARS-CoV-2 INFECTION: A Possible Association. Retina (Philadelphia, Pa.), 41(12), 2462-2471. https://doi.org/10.1097/IAE.0000000000003277
Rabinovitch, Tamar, et al. "UVEITIS AFTER THE BNT162b2 mRNA VACCINATION AGAINST SARS-CoV-2 INFECTION: A Possible Association." Retina (Philadelphia, Pa.) vol. 41,12 (2021): 2462-2471. doi: https://doi.org/10.1097/IAE.0000000000003277
Rabinovitch T, Ben-Arie-Weintrob Y, Hareuveni-Blum T, Shaer B, Vishnevskia-Dai V, Shulman S, Newman H, Biadsy M, Masarwa D, Fischer N, Yovel O, Goldfeather-Ben Zaken S, Habot-Wilner Z. UVEITIS AFTER THE BNT162b2 mRNA VACCINATION AGAINST SARS-CoV-2 INFECTION: A Possible Association. Retina. 2021 Dec 01;41(12):2462-2471. doi: 10.1097/IAE.0000000000003277. PMID: 34369440.
Copy Download .nbib Format: NLM
Bilateral presumed astrocytic hamartomas in a patient with retinitis pigmentosa.

Clinical ophthalmology (Auckland, N.Z.)

Kinori M, Moroz I, Rotenstreich Y, Yonath H, Fabian ID, Vishnevskia-Dai V.
PMID: 22174574
Clin Ophthalmol. 2011;5:1663-5. doi: 10.2147/opth.s23970. Epub 2011 Nov 24.

Retinal astrocytic hamartomas are benign intraocular tumors classically associated with phacomatoses. Their appearance in isolation is rare. An association between astrocytic hamartomas and retinitis pigmentosa (RP) has been described previously, but controversy still exists regarding the precise nature of...

Cite
Kinori M, Moroz I, Rotenstreich Y, et al. Bilateral presumed astrocytic hamartomas in a patient with retinitis pigmentosa. Clin Ophthalmol. 2011;5:1663-5doi: 10.2147/opth.s23970.
Kinori, M., Moroz, I., Rotenstreich, Y., Yonath, H., Fabian, I. D., & Vishnevskia-Dai, V. (2011). Bilateral presumed astrocytic hamartomas in a patient with retinitis pigmentosa. Clinical ophthalmology (Auckland, N.Z.), 51663-5. https://doi.org/10.2147/opth.s23970
Kinori, Michael, et al. "Bilateral presumed astrocytic hamartomas in a patient with retinitis pigmentosa." Clinical ophthalmology (Auckland, N.Z.) vol. 5 (2011): 1663-5. doi: https://doi.org/10.2147/opth.s23970
Kinori M, Moroz I, Rotenstreich Y, Yonath H, Fabian ID, Vishnevskia-Dai V. Bilateral presumed astrocytic hamartomas in a patient with retinitis pigmentosa. Clin Ophthalmol. 2011;5:1663-5. doi: 10.2147/opth.s23970. Epub 2011 Nov 24. PMID: 22174574; PMCID: PMC3236711.
Copy Download .nbib Format: NLM
Optical Coherence Tomography: An Adjunctive Tool for Differentiating between Choroidal Melanoma and Metastasis.

Journal of ophthalmology

Vishnevskia-Dai V, Zur D, Yaacobi S, Moroz I, Newman H, Neudorfer M.
PMID: 26998354
J Ophthalmol. 2016;2016:9803547. doi: 10.1155/2016/9803547. Epub 2016 Feb 22.

Purpose. To investigate the value of optical coherence tomography (OCT) for differentiation between choroidal melanoma and metastasis based on characteristics of the anterior choroidal surface and the chorioretinal interface. Methods. This retrospective observational case series included 29 patients with...

Cite
Vishnevskia-Dai V, Zur D, Yaacobi S, et al. Optical Coherence Tomography: An Adjunctive Tool for Differentiating between Choroidal Melanoma and Metastasis. J Ophthalmol. 2016;2016:9803547doi: 10.1155/2016/9803547.
Vishnevskia-Dai, V., Zur, D., Yaacobi, S., Moroz, I., Newman, H., & Neudorfer, M. (2016). Optical Coherence Tomography: An Adjunctive Tool for Differentiating between Choroidal Melanoma and Metastasis. Journal of ophthalmology, 20169803547. https://doi.org/10.1155/2016/9803547
Vishnevskia-Dai, Vicktoria, et al. "Optical Coherence Tomography: An Adjunctive Tool for Differentiating between Choroidal Melanoma and Metastasis." Journal of ophthalmology vol. 2016 (2016): 9803547. doi: https://doi.org/10.1155/2016/9803547
Vishnevskia-Dai V, Zur D, Yaacobi S, Moroz I, Newman H, Neudorfer M. Optical Coherence Tomography: An Adjunctive Tool for Differentiating between Choroidal Melanoma and Metastasis. J Ophthalmol. 2016;2016:9803547. doi: 10.1155/2016/9803547. Epub 2016 Feb 22. PMID: 26998354; PMCID: PMC4779843.
Copy Download .nbib Format: NLM
Anterior chamber infiltration of CAR T-cells.

American journal of ophthalmology case reports

Jacoby E, Zloto O, Vishnevskia Dai V.
PMID: 34746512
Am J Ophthalmol Case Rep. 2021 Oct 22;24:101223. doi: 10.1016/j.ajoc.2021.101223. eCollection 2021 Dec.

A unique image of anterior chamber infiltration in a 2-year-infant with leukemia, treated with CD19 CAR T cells. Despite significant lymphopenia and resemblance of fungal infection initially, biopsy and cytologic analysis from anterior chamber fluid confirmed that this was...

Cite
Jacoby E, Zloto O, Vishnevskia Dai V. Anterior chamber infiltration of CAR T-cells. Am J Ophthalmol Case Rep. 2021;24:101223doi: 10.1016/j.ajoc.2021.101223.
Jacoby, E., Zloto, O., & Vishnevskia Dai, V. (2021). Anterior chamber infiltration of CAR T-cells. American journal of ophthalmology case reports, 24101223. https://doi.org/10.1016/j.ajoc.2021.101223
Jacoby, Elad, et al. "Anterior chamber infiltration of CAR T-cells." American journal of ophthalmology case reports vol. 24 (2021): 101223. doi: https://doi.org/10.1016/j.ajoc.2021.101223
Jacoby E, Zloto O, Vishnevskia Dai V. Anterior chamber infiltration of CAR T-cells. Am J Ophthalmol Case Rep. 2021 Oct 22;24:101223. doi: 10.1016/j.ajoc.2021.101223. eCollection 2021 Dec. PMID: 34746512; PMCID: PMC8554163.
Copy Download .nbib Format: NLM
An international survey of classification and treatment choices for group D retinoblastoma.

International journal of ophthalmology

Scelfo C, Francis JH, Khetan V, Jenkins T, Marr B, Abramson DH, Shields CL, Pe'er J, Munier F, Berry J, Harbour JW, Yarovoy A, Lucena E, Murray TG, Bhagia P, Paysse E, Tuncer S, Chantada GL, Moll AC, Ushakova T, Plager DA, Ziyovuddin I, Leal CA, Materin MA, Ji XD, Cursino JW, Polania R, Kiratli H, All-Ericsson C, Kebudi R, Honavar SG, Vishnevskia-Dai V, Epelman S, Daniels AB, Ling JD, Traore F, Ramirez-Ortiz MA.
PMID: 28730089
Int J Ophthalmol. 2017 Jun 18;10(6):961-967. doi: 10.18240/ijo.2017.06.20. eCollection 2017.

AIM: To determine which IIRC scheme was used by retinoblastoma centers worldwide and the percentage of D eyes treated primarily with enucleation versus globe salvaging therapies as well as to correlate trends in treatment choice to IIRC version used...

Cite
Scelfo C, Francis JH, Khetan V, et al. An international survey of classification and treatment choices for group D retinoblastoma. Int J Ophthalmol. 2017;10(6):961-967doi: 10.18240/ijo.2017.06.20.
Scelfo, C., Francis, J. H., Khetan, V., Jenkins, T., Marr, B., Abramson, D. H., Shields, C. L., Pe'er, J., Munier, F., Berry, J., Harbour, J. W., Yarovoy, A., Lucena, E., Murray, T. G., Bhagia, P., Paysse, E., Tuncer, S., Chantada, G. L., Moll, A. C., Ushakova, T., Plager, D. A., Ziyovuddin, I., Leal, C. A., Materin, M. A., Ji, X. D., Cursino, J. W., Polania, R., Kiratli, H., All-Ericsson, C., Kebudi, R., Honavar, S. G., Vishnevskia-Dai, V., Epelman, S., Daniels, A. B., Ling, J. D., Traore, F., & Ramirez-Ortiz, M. A. (2017). An international survey of classification and treatment choices for group D retinoblastoma. International journal of ophthalmology, 10(6), 961-967. https://doi.org/10.18240/ijo.2017.06.20
Scelfo, Christina, et al. "An international survey of classification and treatment choices for group D retinoblastoma." International journal of ophthalmology vol. 10,6 (2017): 961-967. doi: https://doi.org/10.18240/ijo.2017.06.20
Scelfo C, Francis JH, Khetan V, Jenkins T, Marr B, Abramson DH, Shields CL, Pe'er J, Munier F, Berry J, Harbour JW, Yarovoy A, Lucena E, Murray TG, Bhagia P, Paysse E, Tuncer S, Chantada GL, Moll AC, Ushakova T, Plager DA, Ziyovuddin I, Leal CA, Materin MA, Ji XD, Cursino JW, Polania R, Kiratli H, All-Ericsson C, Kebudi R, Honavar SG, Vishnevskia-Dai V, Epelman S, Daniels AB, Ling JD, Traore F, Ramirez-Ortiz MA. An international survey of classification and treatment choices for group D retinoblastoma. Int J Ophthalmol. 2017 Jun 18;10(6):961-967. doi: 10.18240/ijo.2017.06.20. eCollection 2017. PMID: 28730089; PMCID: PMC5515152.
Copy Download .nbib Format: NLM
Publication trends in clinical ophthalmology journals in the last decade.

European journal of ophthalmology

Zloto O, Souied E, Saeed P, Ben Simon G, Gildener-Leapman J, Vishnevskia-Dai V, Khatib N, Dray JP.
PMID: 34096347
Eur J Ophthalmol. 2021 Jun 06;11206721211023725. doi: 10.1177/11206721211023725. Epub 2021 Jun 06.

PURPOSE: To examine the absolute number and the proportions of articles published in general high-ranked ophthalmology journals for each ophthalmic subspecialty during the last decade, and to examine the publishing trends over the study period.METHODS: All original articles published...

Cite
Zloto O, Souied E, Saeed P, et al. Publication trends in clinical ophthalmology journals in the last decade. Eur J Ophthalmol. 2021;11206721211023725doi: 10.1177/11206721211023725.
Zloto, O., Souied, E., Saeed, P., Ben Simon, G., Gildener-Leapman, J., Vishnevskia-Dai, V., Khatib, N., & Dray, J. P. (2021). Publication trends in clinical ophthalmology journals in the last decade. European journal of ophthalmology, 11206721211023725. https://doi.org/10.1177/11206721211023725
Zloto, Ofira, et al. "Publication trends in clinical ophthalmology journals in the last decade." European journal of ophthalmology vol. (2021): 11206721211023725. doi: https://doi.org/10.1177/11206721211023725
Zloto O, Souied E, Saeed P, Ben Simon G, Gildener-Leapman J, Vishnevskia-Dai V, Khatib N, Dray JP. Publication trends in clinical ophthalmology journals in the last decade. Eur J Ophthalmol. 2021 Jun 06;11206721211023725. doi: 10.1177/11206721211023725. Epub 2021 Jun 06. PMID: 34096347.
Copy Download .nbib Format: NLM
Showing 1 to 9 of 9 entries